Skip to main content

10 Result(s)

within G B Vogelsang Remove this filter English Remove this filter

and

  1. No Access

    Article

    Skin response using NIH consensus criteria vs Hopkins scale in a phase II study for steroid-refractory chronic GVHD

    One of the obstacles to chronic GVHD research is the lack of standardized response criteria. The National Institute of Health (NIH) has recommended response criteria at a Consensus Conference. These need to be...

    D A Jacobsohn, A Rademaker, M Kaup, G B Vogelsang in Bone Marrow Transplantation (2009)

  2. Article

    Erratum: Toxic absorption of pimecrolimus in a patient with severe acute graft-versus-host disease

    Correction to: Bone Marrow Transplantation (2005) 36, 919–920. doi:10.1038/sj.bmt1705146 My attention has been drawn to the fact that the authors of this letter believed that the patient's cutaneous GvHD was t...

    D L Neuman, J E Farrar, J M Moresi, G B Vogelsang… in Bone Marrow Transplantation (2006)

    Download PDF (55 KB) View Article

  3. No Access

    Article

    Toxic absorption of pimecrolimus in a patient with severe acute graft-versus-host disease

    D L Neuman, J E Farrar, J M Moresi, G B Vogelsang… in Bone Marrow Transplantation (2005)

  4. No Access

    Article

    A case of retroperitoneal fibrosis in a patient following HSCT

    A Nanda, J D Rizzo, G B Vogelsang in Bone Marrow Transplantation (2005)

  5. No Access

    Article

    High incidence of graft failure in children receiving CD34+ augmented elutriated allografts for nonmalignant diseases

    T-cell depletion of the marrow graft using counterflow centrifugal elutriation reduces the risk of graft-versus-host disease (GVHD). However, because of high rates of graft failure and relapse, elutriation alo...

    C H McDonough, D A Jacobsohn, G B Vogelsang, S J Noga… in Bone Marrow Transplantation (2003)

  6. No Access

    Chapter and Conference Paper

    Predictive Models of Graft versus Host Disease

    Graft-versus-host disease (GVHD) remains a major cause of mortality and morbidity following allogeneic bone marrow transplant (BMT) despite major histocompatibility complex (MHC) identity of both the donor and...

    G. B. Vogelsang, A. D. Hess, M. Silanskis… in Recent Advances and Future Directions in B… (1988)

  7. No Access

    Chapter and Conference Paper

    Allogeneic and Autologous Marrow Transplants in Acute Nonlymphoblastic Leukemia (ANLL)

    A number of reports and reviews have presented the rationale, history, and results of bone marrow transplantation in the acute leukemias and lymphomas (1–4). Problems with marrow transplantation such as leukem...

    G. W. Santos, A. M. Yeager, R. Saral… in Recent Advances and Future Directions in B… (1988)

  8. Chapter and Conference Paper

    Syngeneic Graft-versus-Host Disease: Failure of Self: Non-Self Discrimination

    Graft-versus-host disease (GVHD) occurs after allogeneic bone marrow transplantation (BMT) and is primarily thought to be the response of donor lymphocytes to foreign histocompatibility antigens of the recipie...

    A. D. Hess, A. C. Fischer, G. B. Vogelsang… in Recent Advances and Future Directions in B… (1988)

    Download PDF (1102 KB)

  9. No Access

    Chapter

    Bone Marrow Transplantation with HLA Identical Donors in the Acute Leukemias — Baltimore Experience

    The rationale, history, and results in the therapeutic application of allogeneic and syngeneic marrow transplantation in the acute leukemias have been discussed in a number of reports and reviews (1–4). The hu...

    G. W. Santos, R. Saral, W. H. Burns… in Minimal Residual Disease in Acute Leukemia… (1986)

  10. No Access

    Chapter

    Autologous Bone Marrow Transplantation in Acute Nonlymphocytic Leukemia a Study of Ex Vivo Marrow Treatment with 4-Hydroperoxycyclophosphamide

    Current intensive chemotherapeutic regimens for the treatment of acute nonlymphocytic leukemia (ANLL) result in a substantial proportion of patients who enter prolonged first remissions and who may ultimately ...

    A. M. Yeager, H. Kaizer, H. G. Braine… in Minimal Residual Disease in Acute Leukemia… (1986)